Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NB10074350E

Novus Biologicals™ Aggrecan Neoepitope Antibody Blocking Peptide
SDP

Catalog No. NB10074350E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB10074350E 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB10074350E Supplier Novus Biologicals™ Supplier No. NB10074350PEP
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

The Aggrecan Neoepitope Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 176
Species Mouse
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NB100-74350. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias AGC1SEDK, aggrecan, aggrecan core protein, Cartilage-specific proteoglycan core protein, Chondroitin sulfate proteoglycan 1, Chondroitin sulfate proteoglycan core protein 1, CSPCP, CSPG1aggrecan 1, CSPGCP, large aggregating proteoglycan, MSK16AGCAN
Gene Symbol ACAN
Product Type Aggrecan
Quantity 0.1 mg
Regulatory Status RUO - research use only
Termination Synthetic peptide corresponding to residues C G G N(aa 387) I T E G E(aa 392) of human aggrecan
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.